Literature DB >> 7688675

Ring-infected erythrocyte surface antigen (Pf/155RESA) induces tumour necrosis factor-alpha production.

S Picot1, F Peyron, P Deloron, C Boudin, B Chumpitazi, G Barbe, J P Vuillez, A Donadille, P Ambroise-Thomas.   

Abstract

Cerebral malaria is probably related to an overstimulation of the immune system and the cytokine network. We have previously demonstrated that tumour necrosis factor (TNF) secretion by human macrophages can be induced by soluble and heat-stable malarial antigens. Indirect evidence from epidemiological and in vitro studies suggests that Pf155/RESA can be considered as a candidate for triggering TNF secretion. Thus we conducted experiments to investigate the relationship between Pf155/RESA and TNF production. The SGE1 strain of Plasmodium falciparum was compared with the P. falciparum FCR3 strain, which does not express Pf155/RESA protein, for ability to induce TNF secretion by normal human macrophages in vitro. Synthetic peptides from the Pf155/RESA antigen ((EENV)4, (EENVEHDA)4, (DDEHVEEPTVA)3), were used in some experiments. TNF levels were measured by an immunoradiometric assay. We observed that the RESA-defective strain induces lower levels of TNF after schizont rupture than the SGE1 strain. Moreover, substantial TNF secretion was detected when macrophages were incubated with all three peptides, maximum levels being obtained with the (EENV)4 peptide. Although previous reports have described TNF-inducing activity of phospholipid from P. falciparum, these findings strengthen the evidence for Pf155/RESA antigens also being involved in TNF production during malaria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688675      PMCID: PMC1554832          DOI: 10.1111/j.1365-2249.1993.tb07963.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.

Authors:  W E Collins; R F Anders; M Pappaioanou; G H Campbell; G V Brown; D J Kemp; R L Coppel; J C Skinner; P M Andrysiak; J M Favaloro
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

2.  Plasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasion.

Authors:  J G Culvenor; K P Day; R F Anders
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 3.  Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.

Authors:  G E Grau; P F Piguet; P Vassalli; P H Lambert
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

4.  Expression of the RESA gene in Plasmodium falciparum isolate FCR3 is prevented by a subtelomeric deletion.

Authors:  R Cappai; M R van Schravendijk; R F Anders; M G Peterson; L M Thomas; A F Cowman; D J Kemp
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

5.  Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum.

Authors:  S Picot; F Peyron; J P Vuillez; G Barbe; K Marsh; P Ambroise-Thomas
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

6.  Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.

Authors:  J Taverne; C A Bate; D Kwiatkowski; P H Jakobsen; J H Playfair
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.

Authors:  C A Bate; J Taverne; E Román; C Moreno; J H Playfair
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Relationships between clinical protection and antibodies to Plasmodium falciparum RESA (ring-infected erythrocyte surface antigen) peptides.

Authors:  B F Chumpitazi; P Deloron; F Peyron; C Boudin; S Picot; P Ambroise-Thomas
Journal:  Int J Parasitol       Date:  1991-04       Impact factor: 3.981

9.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

10.  Studies on Pf155/RESA and other soluble antigens from in vitro cultured Plasmodium falciparum.

Authors:  J Carlsson; K Berzins; H Perlmann; P Perlmann
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

View more
  2 in total

1.  Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria.

Authors:  P Perlmann; H Perlmann; B W Flyg; M Hagstedt; G Elghazali; S Worku; V Fernandez; A S Rutta; M Troye-Blomberg
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

2.  Signal transduction pathways involved in tumour necrosis factor secretion by Plasmodium falciparum-stimulated human monocytes.

Authors:  S Picot; I Sheick; A Sylvi; A Donadille; P Ambroise-Thomas
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.